Six-minute walking test distance predicts readmission in hospitalized heart failure patient in integrated cardiac centre, Makassar, Indonesia

Idar Mappangara, Peter Kabo, Muzakkir Amir, Zaenab Djafar, Melda Warliani, Asni Mustafa


Background: Assessment of functional capacity prior to discharge can help identify patients at risk for readmissions in heart failure patients. This research aims to conduct a study in order to assess the distance traveled in the six-minute walk test (6-MWT) as a predictor of readmission rates in patients with congestive heart failure.

Methods: This type of research is a quantitative correlational study with a prospective cohort study experimental design. Data were collected when the patient was treated at the Integrated Cardiac Center of Wahidin Sudirohusodo Hospital with a diagnosis of heart failure. The research was conducted from June 2019 to December 2019 after obtaining clearance from the institutional ethical committee. 6-MWT measures the distance that a patient can quickly walk on a flat, hard surface in a period of 6-MWD. To see the correlation between the components of 6-MWT the readmission using one-way anova. To determine the cut-off point, sensitivity and specificity of each component of the 6-MWT to rehospitalization using the receiver operating characteristic (ROC) curve. Statistical analysis was carried out using SPSS and SAP programs.

Results: Out of the 93 samples, the 6-MWD has a significant p<0.001 for the readmission incidence≤30 days, meaning that the higher the 6-MWT value, it correlates with the decrease in the number of readmission incidents. In the ROC curve analysis for the 6-MWD parameter, it was found that the 6-MWD had a good predictability of readmission events in≤30 days (C=0.781, p<0.001).

Conclusions: 6-MWD can be used to predict readmissions in≤30 days in heart failure patients. The lower the 6-MWD with a cut off of 183 meters, the higher the risk of readmission in≤30 days of heart failure patients. By knowing the cut off value, 6-MWD can be used as a reference to create a comprehensive treatment flow for heart failure patients to prevent increased readmission rates. In the end, it can reduce the burden of treatment costs on heart failure patients.  


Heart failure, Readmission, Six-minute walking test

Full Text:



Maharani A, Sujarwoto, Praveen D, Oceandy D, Tampubolon G, Patel A. Cardiovascular disease risk factor prevalence and estimated 10-year cardiovascular risk scores in Indonesia: The SMAR Thealth Extend study. Plos One. 2019;14(4):e0215219.

Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Europ Heart J. 2016;37(27):2129-200.

Balitbangkes. Riset Kesehatan Dasar (Riskesdas) 2013. In: RI KK, editor. Jakarta: Badan Penelitian dan Pengembangan Kesehatan Kementrian Kesehatan RI. 2013.

Ziaeian B, Fonarow GC. The Prevention of Hospital Readmissions in Heart Failure. Prog Cardiovasc Diseas. 2016;58(4):379-85.

Kilgore M, Patel HK, Kielhorn A, Maya JF, Sharma P. Economic burden of hospitalizations of Medicare beneficiaries with heart failure. Risk Managem Heal Care Pol. 2017;10:63-70.

Au AG, McAlister FA, Bakal JA, Ezekowitz J, Kaul P, van Walraven C. Predicting the risk of unplanned readmission or death within 30 days of discharge after a heart failure hospitalization. Am Heart J. 2012;164(3):365-72.

Arena R, Myers J, Williams MA, Gulati M, Kligfield P, Balady GJ, et al. Assessment of functional capacity in clinical and research settings: a scientific statement from the American Heart Association Committee on Exercise, Rehabilitation, and Prevention of the Council on Clinical Cardiology and the Council on Cardiovascular Nursing. Circulation. 2007;116(3):329-43.

Giannitsi S, Bougiakli M, Bechlioulis A, Kotsia A, Michalis LK, Naka KK. 6-minute walking test: a useful tool in the management of heart failure patients. Therapeut Advanc Cardiovasc Disea. 2019;13:1753944719870084.

ATS statement: guidelines for the six-minute walk test. Am J Res Critic Care Med. 2002;166(1):111-7.

Wegrzynowska-Teodorczyk K, Rudzinska E, Lazorczyk M, Nowakowska K, Banasiak W, Ponikowski P, et al. Distance covered during a six-minute walk test predicts long-term cardiovascular mortality and hospitalisation rates in men with systolic heart failure: an observational study. J Physiother. 2013;59(3):177-87.

Zielińska D, Bellwon J, Rynkiewicz A, Elkady MA. Prognostic value of the six-minute walk test in heart failure patients undergoing cardiac surgery: a literature review. Rehabilit Res Pract. 2013;2013:965494.

Naibe TD, Mandi DG, Bamouni J, Yameogo A, Kambiré Y, Kologo K, et al. Six-minute walk test distance and outcome in patients with chronic heart failure. Cardiologie Tunisienne. 2018;14:91-6.

Tabata M, Shimizu R, Kamekawa D, Kato M, Kamiya K, Akiyama A, et al. Six-minute walk distance is an independent predictor of hospital readmission in patients with chronic heart failure. Int Heart J. 2014;55(4):331-6.

Lim NK, Lee SE, Lee HY, Cho HJ, Choe WS, Kim H, et al. Risk prediction for 30-day heart failure-specific readmission or death after discharge: Data from the Korean Acute Heart Failure (KorAHF) registry. J Cardiol. 2019;73(2):108-13.

Mandi DG, Naibe TD, Bamouni J, Yameogo A, Kambiré Y, Kologo K, et al. Long-Term Re-Admission after Hospital Discharge in Patients Admitted with Acute Heart Failure: The Prognostic Value of the Six-Minute Walk Test Distance. O Acce Lib J. 2018;05:1-11.

McCabe N, Butler J, Dunbar SB, Higgins M, Reilly C. Six-minute walk distance predicts 30-day readmission after acute heart failure hospitalization. Heart and Lung. J Cardiopulmon Acut Care. 2017;46(4):287-92.